drug
-
Health & Medicine
Trump’s Investments in Weight-Loss Drug Maker Eli Lilly Spark Ethics Concerns Amid Policy Shifts
President Donald Trump’s public pronouncements on GLP-1 medications, hailed as revolutionary treatments for diabetes and obesity, have taken on new…
Read More » -
Health & Medicine
Supreme Court Preserves Access to Abortion Drug Mifepristone Amidst Ongoing Legal Challenges
WASHINGTON D.C. – In a significant decision that preserves broad access to mifepristone, the most common drug used in medication…
Read More » -
Crime & Justice
Parents Sue OpenAI Alleging ChatGPT Recommendations Contributed to Sons Fatal Drug Overdose
The parents of a 19-year-old college student have filed a high-profile lawsuit against OpenAI, the creator of the popular artificial…
Read More » -
Health & Medicine
France Fines Novo Nordisk and Eli Lilly for Misleading Weight Loss Drug Advertisements
France’s medicine regulator has levied substantial fines against pharmaceutical giants Novo Nordisk and Eli Lilly for engaging in misleading advertising…
Read More » -
Health & Medicine
Maryland Sets Precedent by Capping Diabetes Drug Cost, Paving Way for Broader Affordability Efforts
The Maryland Prescription Drug Affordability Board has taken a significant step in its mission to control healthcare expenses by establishing…
Read More » -
US Politics
Former Rep. Eric Swalwell Faces New Drug and Rape Allegations as Political Career Ends Amid Broader Congressional Misconduct Scandal
Washington – In a stunning culmination of escalating sexual misconduct allegations, former Representative Eric Swalwell (D-Calif.) officially resigned from Congress…
Read More » -
Health & Medicine
A Double-Edged Sword: New Hunter Syndrome Drug Offers Hope, But Age Restrictions Spark Urgent Calls for Equitable Access
The recent Food and Drug Administration (FDA) approval of Avlayah (tividenofusp alfa-eknm) for Hunter syndrome marks a significant advancement in…
Read More » -
Health & Medicine
Ben Sasse on enrolling in Rev Med’s drug trial, more ADC investment, and other biotech news from The Readout
The landscape of cancer therapeutics is in constant flux, with novel approaches emerging as potential game-changers in the fight against…
Read More » -
Health & Medicine
FDA Demands Transparency in Clinical Trial Reporting, While Novo Nordisk and OpenAI Forge AI-Driven Drug Discovery Partnership
The U.S. Food and Drug Administration (FDA) has initiated a significant push for greater transparency in clinical research, dispatching reminder…
Read More »
